Clinical trial
Prevention Of Morbidity In Sickle Cell Disease Pilot Phase
NCT00415727 · Institute of Child Health, Other · Unknown status
Key facts
| NCT number | NCT00415727 |
|---|---|
| Title | Prevention Of Morbidity In Sickle Cell Disease Pilot Phase |
| Lead sponsor | Institute of Child Health, Other |
| Status | Unknown status |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Sickle Cell Anaemia |
| Intervention type | Device |
| Interventions | auto Continuous Positive Airways Pressure (CPAP) with oxygen supplementation |
| Enrollment | 22 |
| Start date | Nov 1, 2006 |
| First posted | Dec 25, 2006 |
| Last update posted | Dec 25, 2006 |
| Countries | United Kingdom |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: